Apex Frozen Foods FY26: The Shrimp That Bounced

General information and entertainment, not investment advice. The author is not a SEBI-registered adviser or research analyst. No recommendation, no promised returns. Markets carry risk including loss of capital. Figures may not be current. Consult a registered adviser before acting.

1. At a Glance

Profit soared 902%. Debt collapsed 92%. Yet revenue barely moved.

The company finished FY26 with ₹931 Cr in sales (up 14% on a TTM basis, but sitting below three-year lows on an annual basis). Net profit jumped to ₹39 Cr from ₹4 Cr. The bounce was real—but ask what caused it.

Apex is an exporter of processed frozen shrimp, entirely 100% export-driven, with hatcheries and farms integrated backward into the supply chain. Geography matters here: the USA accounted for roughly 48% of sales in FY26, Europe 47%, and others 5%. But U.S. tariffs and geopolitical logistics disruptions dominated the year, and management leaned hard on margin recovery and balance-sheet cleanup.

Debt fell from ₹107 Cr (Mar’24) to ₹6 Cr. Borrowings are now negligible. Yet return on equity sits at 7.6% (FY26) and return on capital employed at 10.4%—numbers that whisper, not roar, about capital efficiency.

The multiple sits at 34x earnings, against a peer median of 19x. The company is betting on margin sustenance and U.S. volume recovery. Execution will tell.

2. Introduction

Apex Frozen Foods started as a partnership firm in 1996, shifted to a private limited structure in 2012, and went public in 2017. It sits in Kakinada, Andhra Pradesh, roughly 20 km from a port—proximity that matters in a frozen-shrimp supply chain where every day of cold-chain delay costs margin.

The concall narrative (Jun 2026) focused on one thread: geographic diversification that worked. When the U.S. market seized under tariff and logistics chaos, Apex had already de-risked into Europe. Non-U.S. exports hit 52% of sales in FY26, the highest on record.

Tariffs on shrimp have since normalized from 50% (peak IEEPA tariff) to 10% (current). Management expects U.S. volume to return. EU free-trade agreements are in sight. Capacity utilization sits at only 30% of the 34,240 MTPA facility. Headroom exists.

But Q4 FY26 carried noise: worker disruptions in January trimmed volumes, and logistics constraints (containers, shipping schedules) squeezed quarterly delivery. The bounce in profit came partly from inventory drawdown (earlier-quarter stock consumed at better prices), debt reduction lowering finance costs, and FX tailwinds.

Profitability is “sustainable,” management said. That word needs watching.

3. Business Model: WTF Do They Even Do?

Apex doesn’t trap and sell wild shrimp. It processes farmed shrimp—specifically white-leg vannamei and black tiger varieties—into finished frozen products for export.

The backward integration runs four steps. First: own hatcheries produce 1.2–1.4 billion SPF (specific pathogen free) seeds per year. Second: outsourced farms (managed by Apex but owned by others) rear the shrimp in bio-secured ponds. Third: in-house processing plants (two units, 34,240 MTPA capacity) grade, debone, peel, cook, and freeze. Products range from commodity “head-on shell-on” shrimp (low value) to ready-to-eat skewered, seasoned, breaded variants (higher margin). Ready-to-eat products grew to 12% of sales in FY26 from 10% in FY25. Fourth: in-house cold storage and owned refrigerated trucks handle logistics to port and beyond.

The model is resilient to supply shocks (own seeds), vulnerable to disease (aquaculture risk), and acutely sensitive to realizations (USD pricing of shrimp fluctuates with global supply imbalances). Currency risk is only partially hedged: 30% max of forex exposure, leaving 70% naked to INR moves.

Customers are large HORECA chains, retail franchises, and distributors in the U.S., EU, and China. The company sells under customer brands and in-house brands (Bay Fresh, Bay Harvest, Bay Premium). Export incentives (rebates for indirect taxes reimbursed) contributed ₹493 Cr to FY26 revenue, about 5.3% of sales. This is a policy lever, not a durable moat.

4. Financials Overview

Figures are consolidated, in ₹ crore.

Full Year (FY26 vs FY25):

Q4 FY26 landed softer than Q3. Revenue slid 30% QoQ; management attributed it to operational disruptions (worker unrest, container availability, logistics delays around January) and seasonal shipping patterns. But profitability doubled YoY, with margins expanding 593 bps in the quarter—a sign that per-unit costs improved (either through mix, realization, or drawdown of costlier inventory from earlier quarters).

Concall framing: Management credited margin improvement to (a) inventory use from prior quarters (the company had stockpiled at higher costs; FY26 used that stock at beneficiary prices), (b) debt reduction (less finance cost), (c) process efficiencies, and (d) benign raw material pricing for a window. Sustainability of FY26-level margins is framed as the near-term target, not a floor.

5. Market Expectations & Historical Multiples

This section describes how the market is currently pricing the company and how that compares with its own history and peer group. It is descriptive, not predictive.

The market currently pays 34.4x earnings for Apex, versus its own five-year average of 19.5x. On EV/EBITDA, the gap is tighter: 18.2x current versus 14.3x historical average. Peers trade at a median P/E of 19x—a 15-point gap.

This pricing appears to embed confidence in margin recovery and U.S. volume rebound post-tariff normalization. Alternatively, it reflects the rarity of a leveraged-balance-sheet turnaround in the fragmented seafood sector: most peers carry higher leverage and weaker financial risk profiles. Apex’s net cash position (—0.02x debt/equity) is an outlier.

ROE at 7.6% trails the peer median of 8.2%, yet ROCE sits at the peer median (10.4% vs 12.5% peer band). The gap suggests that earnings are concentrated in equity rather than capital-efficient deployment across all capital sources.

6. What’s Cooking

Tariff rollback: IEEPA tariffs dropped from near 50% to 10%. U.S. demand is expected to recover. Management flagged confidence but also caution: uncertainties are “increasing” and “sudden incidents” disrupt trade.

EU free-trade opportunities: FTAs with the U.K. and EU are in negotiation. Approval of the second facility for RTE (ready-to-eat) products in the EU is pending regulatory clearance. If approved, this unlocks 10,000 MTPA of RTE capacity in Europe—a higher-margin segment.

Geographic diversification locked in: Non-U.S. markets hit 52% of FY26 sales. Management stated explicitly it will not re-concentrate in the U.S. even if volume recovers. This hedges future tariff shocks.

Logistics as a constraint: Shipping delays (3–5 days, sometimes a week), container unavailability, and equipment shortages remain the real gating factor, not demand. Volumes are ready; execution is the bottleneck.

Raw material and realization: Farm-gate prices are seasonally stable (currently ₹340–348/kg in Q1; FY26 average ₹327/kg). Realizations sit around $9.1–9.2/kg, down from $9.5–9.7/kg in FY26. The margin between realization and input cost is tightening.

Debt elimination and capex discipline: The company is no longer in debt mode. Minimal capex is planned; both facilities are operational. Cash generation is being returned to shareholders (final dividend recommended ₹2.50/share, 25% payout on FV of ₹10).

7. Balance Sheet

Assets are shrinking (₹633 Cr → ₹593 Cr), but that’s not a red flag. Inventory is down (from ₹194 Cr to ₹167 Cr), receivables have normalized (₹127 Cr → ₹109 Cr), and capex is dormant. Equity base is stable. Borrowings are now trivial.

Three notes: The company holds ₹18.5 Cr in cash (up from ₹5.2 Cr), a minor fortress. Debt reduction ate into financing cash flow, so equity now funds any growth. The balance sheet validates the narrative—a company that was once leveraged (₹163 Cr debt in FY21) is now nearly clean, funded by retained earnings and a pause on growth capex.

Yet this restraint raises a whisper: if capacity utilization is only 30%, why not deploy cash into ramp-up? The concall mentioned production constraints (logistics, seasonality), not capital starvation. In other words, the company isn’t choked for cash; it’s choked for execution.

8. Cash Flow: Sab Number Game Hai

Operating cash flow doubled from FY25 to FY26 (₹50 Cr → ₹96 Cr), a strong signal. Investing outflows are minimal (₹1.7 Cr), confirming the capex pause. Financing outflows are aggressive: ₹77.8 Cr flowed out, mostly repayment of short-term borrowings. This is deleveraging, not distribution.

Free cash flow (CFO − CFI) was ₹94 Cr in FY26, up sharply. On a ₹39 Cr net profit, that’s a 192% conversion to free cash—a sign that working capital improved (receivables and inventory both came down).

The trajectory is: earn it, collect it fast, repay debt, repeat. No capex, no acquisitions, no shareholder distributions beyond the interim dividend. This is a company in financial repair, not one gunning for growth.

9. Ratios: Sexy or Stressy?

ROE of 7.6% is unimpressive—the equity is earning below the risk-free rate in many markets. But that’s a legacy of FY25 near-collapse (₹3.9 Cr profit on ₹528 Cr equity). FY26 recovery lifts the number. Going forward, if the company can sustain ₹40+ Cr annual PAT, ROE will climb toward 8–10%, still pedestrian but no longer alarming.

ROCE at 10.4% is inline with the peer band. The company deploys about ₹530 Cr of capital (equity + net debt) and earns ₹53 Cr before tax, a 10% return. Not stellar; not catastrophic.

Net profit margin of 4.2% is below the peer median of ~5–6% and below Apex’s own historical average (~4.5% in better years). Margin is the crux: if tariff normalization + EU approvals lift volume and realizations, margins will compress unless the company can hold costs. The concall hinted at some near-term headwinds (current realizations are lower than FY26 average), so margin pressure is real.

10. P&L Breakdown: Show Me the Money

The arc: revenue stalled for three years (FY24–25 nearly flat at ₹804–814 Cr), then jumped 14% to ₹931 Cr. EBITDA tells a darker story: FY24 saw 4.9% margin, FY25 collapsed to 3.6% (raw material inflation + demand weakness), FY26 recovered to 7.7%. PAT swung wildly because of that mix, tax rate, and finance cost.

What’s missing: the reason for FY24–25 revenue stagnation. Management on the concall attributed FY25 pain to “higher raw material prices and muted demand amid global uncertainties.” FY26 benefited from “firm global shrimp prices and favorable currency movements.” Translation: commodity pricing, not volume leverage.

Shrimp volume exported in FY26 was 10,286 MT (per concall notes), near flat versus FY25 (10,534 MT). Revenue per kg improved due to realization uptick and FX. In other words, the 14% topline growth was largely pricing and currency, not volume. For a company claiming growth via “geometric expansion” into new geographies, this is a yellow flag.

11. Peer Comparison

Apex sits in the mid-tier by size. Coastal Corporat is larger (₹327 Cr, 9x PAT), more diversified (shrimp + other seafood), and trades at 12x—Apex is at 34x the peer median. That gap persists because Apex’s risk profile is unique: net cash, integrated backward, geographic diversification locked in. But the multiple also prices in margin recovery and U.S. volume upside that is not yet materialized.

Versus Coastal: Apex has higher ROCE (10.4% vs 9.6%), lower leverage (0.01 vs ~0.2 D/E), and a smaller absolute profit (₹39 Cr vs ₹99 Cr). The peer is larger, more profitable, and trades at a discount. Seasonally, shrimp processors all face the same input cost pressures; integration doesn’t inoculate against them.

12. Miscellaneous: Shareholding & Promoters

Promoters (Karuturi brothers, Subrahmanya Chowdary 30.9%, Satyanarayana Murthy 28.5%, and others) hold a supermajority at 72.6%, unchanged in recent quarters. No pledges, no sudden exits. FII holding has risen from 0% to 6% over FY26, a modest sign of non-resident institutional interest.

A short note on the promoters: in January 2023, SEBI imposed penalties on two promoters for insider trading violations (post-IPO trading during blackout windows). The fine was material in symbol but minor in quantum. It flags governance frictions but not disqualifying fraud. The board reappointed the executive chairman and MD in September 2025 with increased managerial remuneration limits (16% → 26%).

13. Corporate Governance: Angels or Devils?

Auditors are Padmanabhan Ramani & Ramanujam (small Bangalore-based CA firm), and the audit report is unmodified (clean opinion) for FY26. Board comprises the executive chairman, MD, one independent director, and others (limited details in public filings).

Red flags spotted: CRISIL downgraded Apex’s short-term bank ratings from A2+ to A2 in August 2025, citing margin compression in FY24–25 (OPM fell to 3.1% in FY25 from 7.8% in FY23). The rating agency cautioned that “ability of the company to improve profitability will remain monitorable.” That downgrade happened before FY26 results were announced; the recovery since then has not yet triggered an upgrade notice (as of Jun 2026).

Related-party transactions: None flagged in the filings.

Pledges: Zero. Promoter holdings are unencumbered.

Tax demands: No material income-tax or indirect-tax disputes mentioned in recent announcements.

The governance posture is tight, if unremarkable. No smoking guns. The SEBI penalty from 2023 is a historic blot, not a current concern.

14. Industry Roast & Macro Context

The Indian shrimp sector is export-dependent: 98% of India’s aquaculture output hits foreign markets. The U.S., EU, and Southeast Asia are the consumption centers. Margins are thin, competition is global, and every country with a coastline and a labor-cost arbitrage plays.

Pricing wars: Shrimp is a commodity—Vietnam, Ecuador, Indonesia, and Thailand all produce vannamei at lower farm-gate costs than India in many seasons. Apex’s differentiation (SPF seeds, value-add via RTE, geographic diversity) buys a modest premium, but it’s not structural. A glut in Ecuador, a supply shock in Vietnam, or a disease outbreak in India instantly resets realizations.

Logistics: Shipping container costs, bunker fuel prices, and geopolitical routing (Red Sea chaos, Middle East insurance premiums) ripple through margins. Apex is not insulated.

Regulatory: EU food-safety rules (HACCP, traceability) are stringent; so are U.S. import protocols. Non-compliance can halt shipments. Both Apex facilities are certified, but standards creep (environmental, labor, sustainability) adds capex pressure.

Macro: Global recession weakens HORECA demand (hotels, restaurants contract in downturns). Currency volatility (INR depreciation helps exports, appreciation hurts). Trade wars (U.S.–China tariffs, now IEEPA on shrimp) are structural risks. None of these move in Apex’s favor by default.

The sector is consolidated at the buyer end (large retailers, food companies) and fragmented at the producer end (hundreds of processors). Apex’s size is respectable but not dominant. Pricing power is thin.

15. EduInvesting Verdict

The core tension: Apex has engineered a financial turnaround (debt to net cash, profit from ₹4 Cr to ₹39 Cr) on essentially flat volumes. The bounce was margin and FX, not volume. U.S. tariff normalization and EU approvals are catalysts in waiting, not closed loops. The multiple of 34x prices in that upside; current execution does not yet confirm it.

If volumes scale (U.S. recovery, EU RTE approvals), margins sustain, and the company returns cash to equity, the case sharpens. If realizations compress further and logistics remain a persistent brake, the multiple re-rates lower. Neither outcome is guaranteed or close.

A balance sheet with nothing to hide. A multiple with everything to prove.

Prices referenced are not live; they are as of June 15, 2026.